Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
about
Current management and prognostic features for gastrointestinal stromal tumor (GIST)Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumorsNovel biomarkers for diagnosis, prognosis, targeted therapy and clinical trialsPlatelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.STAT inhibitors for cancer therapy.Upregulation of Atoh1 correlates with favorable survival in gastrointestinal stromal tumor.Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.Nephrotoxicity of recent anti-cancer agents.Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions.Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong pathOverexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors.Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome.CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosisPhosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics.Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma.Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy.An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).Ibrutinib and novel BTK inhibitors in clinical development.Colonic gastrointestinal stromal tumor resulting in recurrent colic and hematochezia in a warmblood gelding.Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies.
P2860
Q28391684-8A294B81-8C4C-434D-9E7D-A85C225B2C88Q28602517-DBE4823C-6EA9-438B-B2C0-3D728A127947Q28680693-6EF31D63-DAD7-45C8-813D-9EC5D2B5578DQ30250273-927A4C04-87F5-4EEB-9A2D-600ED2660873Q33644206-DF3C6E49-E907-4861-B088-C33C41DDF45FQ34501902-9180F48C-A430-425A-8CCA-6CD30DF260F6Q34974255-E7140190-062D-4B71-8F01-F26AB6F48BC7Q35310741-E7F2B13F-3C87-4330-97C8-9B893AAACA65Q36474669-E2D01104-D12E-484B-90CE-84057B66B28DQ36753291-34589EC0-67F8-4377-8BA4-73C6B7BC06DCQ36821619-CB212255-4903-4088-8CD5-8454C423CE23Q37249829-B5DF5EE7-5FC2-49BD-BF89-1108AAB51C13Q37269065-36A37A7C-359A-43E5-A332-06DADC7A27C1Q37350230-CC850C86-0377-4F4D-868D-FE618ACA8F74Q37482664-12762B2B-68AD-4CBA-A0CD-7938B2006CA2Q38112821-756EA1DB-3C6F-4A6B-A403-EFD28C45F784Q38119931-1CA5CCFC-FBF7-474D-9431-13D8F639FC13Q38130010-9DBA7C6B-7630-43F2-9BEE-F661B9AD6B1CQ38836253-4604D46E-1D76-4ECF-8A35-0954019BB29CQ38925022-9914F090-81ED-402A-B527-50FB1F05C182
P2860
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
@ast
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
@en
type
label
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
@ast
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
@en
prefLabel
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
@ast
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
@en
P2093
P2860
P356
P1476
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
@en
P2093
Delong Liu
Gurpreet Lamba
Ridhi Gupta
Samir Ambrale
Shamudheen M Rafiyath
P2860
P2888
P356
10.1186/1756-8722-5-21
P5008
P577
2012-05-08T00:00:00Z
P5875
P6179
1010718121